よむ、つかう、まなぶ。
参考資料4 有効性評価に基づく子宮頸がん検診ガイドライン更新版2020年３月31日 (60 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_25869.html |
| 出典情報 | がん検診のあり方に関する検討会（第35回 5／25）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the
POBASCAM randomised controlled trial. Lancet Oncol. 2012; 13(1): 78-88.
10） Kitchener HC, Gilham C, Sargent A, Bailey A, Albrow R, Roberts C, Desai M,
Mather J, Turner A, Moss S, Peto J. A comparison of HPV DNA testing and liquid based
cytology over three rounds of primary cervical screening: Extended follow up in the
ARTISTIC trial. Eur J Cancer. 2011; 47(6): 864-871.
11） Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander
B, Forslund O, Hansson BG, Rylander E, Dillner J. Human papillomavirus and
Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007; 357(16): 1589-1597.
12） Leinonen MK, Nieminen P, Lönnberg S, Malila N, Hakama M, Pokhrel A, Laurila P,
Tarkkanen J, Anttila A. Detection rates of precancerous and cancerous cervical lesions
within one screening round of primary human papillomavirus DNA testing: prospective
randomised trial in Finland. BMJ. 2012; 345: e7789.
13） Ogilvie GS, Krajden M, van Niekerk D, Smith LW, Cook D, Ceballos K, Lee M,
Gentile L, Gondara L, Elwood-Martin R, Peacock S, Stuart G, Franco EL, Coldman AJ.
HPV for cervical cancer screening (HPV FOCAL): complete round 1 results of a
randomized trial comparing HPV-based primary screening to liquid-based cytology for
cervical cancer. Int J Cancer. 2017; 140(2): 440-448.
14） Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM,
Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, Kane S, Desai S, Keskar
VR, Rajeshwarkar R, Panse N, Dinshaw KA. HPV screening for cervical cancer in rural
India. N Engl J Med. 2009; 360(14): 1385-1394.
15） Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H,
Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJ; International HPV
screening working group. Efficacy of HPV-based screening for prevention of invasive
cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;
383(9916): 524-532.
16） Pan Q, Belinson JL, Li L, Pretorius RG, Qiao YL, Zhang WH, Zhang X, Wu LY, Rong
SD, Sun YT. A thin-layer, liquid-based pap test for mass screening in an area of China
with a high incidence of cervical carcinoma. A cross-sectional, comparative study. Acta
Cytol. 2003; 47(1): 45-50.
17） Zhao FH, Zhang WH, Pan QJ, Zhang X, Chen W, Liu B, Ma JF, Hu SY, Qiao YL. A
study of cervical cancer screening algorithms. Chin J Oncol. 2010; 32(6): 420-424.
Chinese
18 ） Sankaranarayanan R, Chatterji R, Shastri SS, Wesley RS, Basu P, Mahe C,
Muwonge R, Seigneurin D, Somanathan T, Roy C, Kelkar R, Chinoy R, Dinshaw K,
POBASCAM randomised controlled trial. Lancet Oncol. 2012; 13(1): 78-88.
10） Kitchener HC, Gilham C, Sargent A, Bailey A, Albrow R, Roberts C, Desai M,
Mather J, Turner A, Moss S, Peto J. A comparison of HPV DNA testing and liquid based
cytology over three rounds of primary cervical screening: Extended follow up in the
ARTISTIC trial. Eur J Cancer. 2011; 47(6): 864-871.
11） Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander
B, Forslund O, Hansson BG, Rylander E, Dillner J. Human papillomavirus and
Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007; 357(16): 1589-1597.
12） Leinonen MK, Nieminen P, Lönnberg S, Malila N, Hakama M, Pokhrel A, Laurila P,
Tarkkanen J, Anttila A. Detection rates of precancerous and cancerous cervical lesions
within one screening round of primary human papillomavirus DNA testing: prospective
randomised trial in Finland. BMJ. 2012; 345: e7789.
13） Ogilvie GS, Krajden M, van Niekerk D, Smith LW, Cook D, Ceballos K, Lee M,
Gentile L, Gondara L, Elwood-Martin R, Peacock S, Stuart G, Franco EL, Coldman AJ.
HPV for cervical cancer screening (HPV FOCAL): complete round 1 results of a
randomized trial comparing HPV-based primary screening to liquid-based cytology for
cervical cancer. Int J Cancer. 2017; 140(2): 440-448.
14） Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM,
Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, Kane S, Desai S, Keskar
VR, Rajeshwarkar R, Panse N, Dinshaw KA. HPV screening for cervical cancer in rural
India. N Engl J Med. 2009; 360(14): 1385-1394.
15） Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H,
Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJ; International HPV
screening working group. Efficacy of HPV-based screening for prevention of invasive
cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;
383(9916): 524-532.
16） Pan Q, Belinson JL, Li L, Pretorius RG, Qiao YL, Zhang WH, Zhang X, Wu LY, Rong
SD, Sun YT. A thin-layer, liquid-based pap test for mass screening in an area of China
with a high incidence of cervical carcinoma. A cross-sectional, comparative study. Acta
Cytol. 2003; 47(1): 45-50.
17） Zhao FH, Zhang WH, Pan QJ, Zhang X, Chen W, Liu B, Ma JF, Hu SY, Qiao YL. A
study of cervical cancer screening algorithms. Chin J Oncol. 2010; 32(6): 420-424.
Chinese
18 ） Sankaranarayanan R, Chatterji R, Shastri SS, Wesley RS, Basu P, Mahe C,
Muwonge R, Seigneurin D, Somanathan T, Roy C, Kelkar R, Chinoy R, Dinshaw K,